Global Intravenous Immunoglobulin (IVIg) Market Research Report 2025(Status and Outlook)

March 2025 | 234 pages | ID: GBCDC494D26CEN
Bosson Research

Abstracts

Report Overview

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

This report provides a deep insight into the global Intravenous Immunoglobulin (IVIg) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Immunoglobulin (IVIg) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Immunoglobulin (IVIg) market in any manner.

Global Intravenous Immunoglobulin (IVIg) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Market Segmentation (by Type)

IVIg Liquid

IVIg Powder

Market Segmentation (by Application)

Immunodeficiency

Autoimmune Disease

Acute Infection

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Intravenous Immunoglobulin (IVIg) Market
• Overview of the regional outlook of the Intravenous Immunoglobulin (IVIg) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Immunoglobulin (IVIg) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Intravenous Immunoglobulin (IVIg)
1.2 Key Market Segments
  1.2.1 Intravenous Immunoglobulin (IVIg) Segment by Type
  1.2.2 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Intravenous Immunoglobulin (IVIg) Product Life Cycle
3.3 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2020-2025)
3.4 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2020-2025)
3.5 Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
3.8 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
  3.8.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 INTRAVENOUS IMMUNOGLOBULIN (IVIG) INDUSTRY CHAIN ANALYSIS

4.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Intravenous Immunoglobulin (IVIg) Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Intravenous Immunoglobulin (IVIg) Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET BY REGION

6.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region
  6.1.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region
  6.1.2 Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region
6.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region
  6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region
  6.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
7.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
8.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type
9.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Intravenous Immunoglobulin (IVIg) Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Intravenous Immunoglobulin (IVIg) Market Size by Type
10.3 South America Intravenous Immunoglobulin (IVIg) Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type
11.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application

12 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET PRODUCTION BY REGION

12.1 Global Production of Intravenous Immunoglobulin (IVIg) by Region(2020-2025)
12.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2025)
12.3 Global Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Intravenous Immunoglobulin (IVIg) Production
  12.4.1 North America Intravenous Immunoglobulin (IVIg) Production Growth Rate (2020-2025)
  12.4.2 North America Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Intravenous Immunoglobulin (IVIg) Production
  12.5.1 Europe Intravenous Immunoglobulin (IVIg) Production Growth Rate (2020-2025)
  12.5.2 Europe Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Intravenous Immunoglobulin (IVIg) Production (2020-2025)
  12.6.1 Japan Intravenous Immunoglobulin (IVIg) Production Growth Rate (2020-2025)
  12.6.2 Japan Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Intravenous Immunoglobulin (IVIg) Production (2020-2025)
  12.7.1 China Intravenous Immunoglobulin (IVIg) Production Growth Rate (2020-2025)
  12.7.2 China Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2020-2025)

13 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2033)
13.3 Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Type (2020-2033)
13.4 Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2033)

14 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Intravenous Immunoglobulin (IVIg) Market Sales by Application (2020-2033)
14.3 Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2033)
14.4 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Baxter
  15.1.1 Baxter Basic Information
  15.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Overview
  15.1.3 Baxter Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.1.4 Baxter Business Overview
  15.1.5 Baxter SWOT Analysis
  15.1.6 Baxter Recent Developments
15.2 Grifols
  15.2.1 Grifols Basic Information
  15.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Overview
  15.2.3 Grifols Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.2.4 Grifols Business Overview
  15.2.5 Grifols SWOT Analysis
  15.2.6 Grifols Recent Developments
15.3 CSL
  15.3.1 CSL Basic Information
  15.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Overview
  15.3.3 CSL Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.3.4 CSL Business Overview
  15.3.5 CSL SWOT Analysis
  15.3.6 CSL Recent Developments
15.4 Octapharma
  15.4.1 Octapharma Basic Information
  15.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Overview
  15.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.4.4 Octapharma Business Overview
  15.4.5 Octapharma Recent Developments
15.5 Biotest
  15.5.1 Biotest Basic Information
  15.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Overview
  15.5.3 Biotest Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.5.4 Biotest Business Overview
  15.5.5 Biotest Recent Developments
15.6 Kedrion
  15.6.1 Kedrion Basic Information
  15.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Overview
  15.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.6.4 Kedrion Business Overview
  15.6.5 Kedrion Recent Developments
15.7 Hualan Bio
  15.7.1 Hualan Bio Basic Information
  15.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Overview
  15.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.7.4 Hualan Bio Business Overview
  15.7.5 Hualan Bio Recent Developments
15.8 CNBG
  15.8.1 CNBG Basic Information
  15.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Overview
  15.8.3 CNBG Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.8.4 CNBG Business Overview
  15.8.5 CNBG Recent Developments
15.9 Shanghai RAAS
  15.9.1 Shanghai RAAS Basic Information
  15.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Overview
  15.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.9.4 Shanghai RAAS Business Overview
  15.9.5 Shanghai RAAS Recent Developments
15.10 CBPO
  15.10.1 CBPO Basic Information
  15.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Overview
  15.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.10.4 CBPO Business Overview
  15.10.5 CBPO Recent Developments
15.11 LFB Group
  15.11.1 LFB Group Basic Information
  15.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Overview
  15.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.11.4 LFB Group Business Overview
  15.11.5 LFB Group Recent Developments
15.12 BPL
  15.12.1 BPL Basic Information
  15.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Overview
  15.12.3 BPL Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.12.4 BPL Business Overview
  15.12.5 BPL Recent Developments
15.13 Sichuan Yuanda Shuyang
  15.13.1 Sichuan Yuanda Shuyang Basic Information
  15.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Overview
  15.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Market Performance
  15.13.4 Sichuan Yuanda Shuyang Business Overview
  15.13.5 Sichuan Yuanda Shuyang Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 5. Intravenous Immunoglobulin (IVIg) Market Size Comparison by Region (M USD)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
Table 11. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites and Area Served
Table 13. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 14. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Intravenous Immunoglobulin (IVIg) Market Size Comparison by Region (M USD)
Table 26. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (2020-2033) & (M USD)
Table 27. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region (2020-2033)
Table 28. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2033) & (K MT)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2033)
Table 30. North America Intravenous Immunoglobulin (IVIg) Market Size by Country (2020-2033) & (M USD)
Table 31. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2033) & (K MT)
Table 32. North America Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 33. North America Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 34. North America Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 35. North America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2033)
Table 36. North America Intravenous Immunoglobulin (IVIg) Sales by Application (K MT)
Table 37. North America Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 38. North America Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2020-2033)
Table 39. North America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2033)
Table 40. Europe Intravenous Immunoglobulin (IVIg) Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2033) & (K MT)
Table 42. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 43. Europe Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 44. Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 45. Europe Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2033)
Table 46. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (K MT)
Table 47. Europe Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 48. Europe Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2020-2033)
Table 49. Europe Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 53. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 54. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (K MT)
Table 57. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 58. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2025)
Table 60. South America Intravenous Immunoglobulin (IVIg) Market Size by Country (2020-2033) & (M USD)
Table 61. South America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2033) & (K MT)
Table 62. South America Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 63. South America Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 64. South America Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 65. South America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2033)
Table 66. South America Intravenous Immunoglobulin (IVIg) Sales by Application (K MT)
Table 67. South America Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 68. South America Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2020-2033)
Table 69. South America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 73. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 74. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (K MT)
Table 77. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application (M USD)
Table 78. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2020-2033)
Table 80. Global Intravenous Immunoglobulin (IVIg) Production (K MT) by Region(2020-2025)
Table 81. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2025)
Table 83. Global Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 89. Global Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 90. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2020-2033)
Table 91. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2033)
Table 92. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2020-2033)
Table 93. Global Intravenous Immunoglobulin (IVIg) Market Size Share by Type (2020-2033)
Table 94. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application
Table 95. Global Intravenous Immunoglobulin (IVIg) Market Size by Application(M USD)
Table 96. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2033) & (K MT)
Table 97. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2033)
Table 98. Global Intravenous Immunoglobulin (IVIg) Market Size by Application (2020-2033) & (M USD)
Table 99. Global Intravenous Immunoglobulin (IVIg) Market Share by Application (2020-2033)
Table 100. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2020-2033)
Table 101. Baxter Basic Information
Table 102. Baxter Intravenous Immunoglobulin (IVIg) Product Overview
Table 103. Baxter Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Baxter Business Overview
Table 105. Baxter SWOT Analysis
Table 106. Baxter Recent Developments
Table 107. Grifols Basic Information
Table 108. Grifols Intravenous Immunoglobulin (IVIg) Product Overview
Table 109. Grifols Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Grifols Business Overview
Table 111. Grifols SWOT Analysis
Table 112. Grifols Recent Developments
Table 113. CSL Basic Information
Table 114. CSL Intravenous Immunoglobulin (IVIg) Product Overview
Table 115. CSL Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. CSL Business Overview
Table 117. CSL SWOT Analysis
Table 118. CSL Recent Developments
Table 119. Octapharma Basic Information
Table 120. Octapharma Intravenous Immunoglobulin (IVIg) Product Overview
Table 121. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Octapharma Business Overview
Table 123. Octapharma Recent Developments
Table 124. Biotest Basic Information
Table 125. Biotest Intravenous Immunoglobulin (IVIg) Product Overview
Table 126. Biotest Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Biotest Business Overview
Table 128. Biotest Recent Developments
Table 129. Kedrion Basic Information
Table 130. Kedrion Intravenous Immunoglobulin (IVIg) Product Overview
Table 131. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Kedrion Business Overview
Table 133. Kedrion Recent Developments
Table 134. Hualan Bio Basic Information
Table 135. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Overview
Table 136. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Hualan Bio Business Overview
Table 138. Hualan Bio Recent Developments
Table 139. CNBG Basic Information
Table 140. CNBG Intravenous Immunoglobulin (IVIg) Product Overview
Table 141. CNBG Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. CNBG Business Overview
Table 143. CNBG Recent Developments
Table 144. Shanghai RAAS Basic Information
Table 145. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Overview
Table 146. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Shanghai RAAS Business Overview
Table 148. Shanghai RAAS Recent Developments
Table 149. CBPO Basic Information
Table 150. CBPO Intravenous Immunoglobulin (IVIg) Product Overview
Table 151. CBPO Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. CBPO Business Overview
Table 153. CBPO Recent Developments
Table 154. LFB Group Basic Information
Table 155. LFB Group Intravenous Immunoglobulin (IVIg) Product Overview
Table 156. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. LFB Group Business Overview
Table 158. LFB Group Recent Developments
Table 159. BPL Basic Information
Table 160. BPL Intravenous Immunoglobulin (IVIg) Product Overview
Table 161. BPL Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. BPL Business Overview
Table 163. BPL Recent Developments
Table 164. Sichuan Yuanda Shuyang Basic Information
Table 165. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Overview
Table 166. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Sichuan Yuanda Shuyang Business Overview
Table 168. Sichuan Yuanda Shuyang Recent Developments
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD), 2024-2033
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) (2020-2033)
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intravenous Immunoglobulin (IVIg) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Intravenous Immunoglobulin (IVIg) Product Life Cycle
Figure 13. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2024
Figure 14. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2024
Figure 15. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2024
Figure 18. Industry Chain Map of Intravenous Immunoglobulin (IVIg)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Market PEST Analysis
Figure 20. Global Intravenous Immunoglobulin (IVIg) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Intravenous Immunoglobulin (IVIg) Market Size by Region
Figure 27. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region (2020-2033)
Figure 28. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Country
Figure 33. USA Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Intravenous Immunoglobulin (IVIg) Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Intravenous Immunoglobulin (IVIg) Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Intravenous Immunoglobulin (IVIg) Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Intravenous Immunoglobulin (IVIg) Market Size (M USD)by Type
Figure 40. North America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Country
Figure 45. Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type
Figure 56. Europe Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Country
Figure 61. China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type
Figure 72. Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Country
Figure 77. Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type
Figure 84. South America Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Country
Figure 89. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type
Figure 100. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application
Figure 101. Global Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2020-2025)
Figure 102. North America Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2020-2025)
Figure 105. China Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Figure 108. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2033)
Figure 109. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2024
Figure 110. Market Size Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2033)
Figure 111. Market Size Share of Intravenous Immunoglobulin (IVIg) by Type in 2024
Figure 112. Global Intravenous Immunoglobulin (IVIg) Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Intravenous Immunoglobulin (IVIg) Market Size by Application(M USD)
Figure 115. Global Intravenous Immunoglobulin (IVIg) Market Share by Application
Figure 116. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2033)
Figure 117. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2024
Figure 118. Global Intravenous Immunoglobulin (IVIg) Market Share by Application (2020-2033)
Figure 119. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2024
Figure 120. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2020-2033)